surpass-cvot tirzepatide 🫀 EASD 2025: (SURPASS-CVOT) Dulaglutide head-to-head showdown: ✓ Noninferior for MACE ✓ 16% ↓ all-cause mortality ✓ Superior in A1C & weight loss Tirzepatide confirms its broad cardiometabolic edge. #EASD2025 # Tirzepatide #GLP1 What do topline data from

The same four-compound blend GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg and KPV 10mg pre-reconstituted as an 80mg/3ml liquid in a pen-compatible vial

Ooi SL, Henikoff JG, Henikoff S

Physical activity stimulates peristalsis

In the context of reproductive health, replenishing myo-inositol levels directly addresses the "Ovarian Paradox." By providing a high dose (2,000 mg) of myo-inositol alongside a carefully controlled dose (50 mg) of D-chiro-inositol, the supplement restores the critical 40:1 physiological ratio

All the remaining patients (n=45) were evaluated for luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol (E2), progesterone (P), androstenedione (A), testosterone (T), insulin, C peptide, total cholesterol, HDL, LDL, glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) concentrations

Because tirzepatide suppresses your appetite, stopping treatment can cause your appetite to return